- €3.08bn
- €5.57bn
- €313.04m
- 44
- 32
- 80
- 50
2019 June 30th | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 18 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 118 | 256 | 231 | 272 | 313 |
Cost of Revenue | |||||
Gross Profit | 113 | 249 | 224 | 266 | 305 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | -49.5 | 19.7 | -119 | -25.7 | 218 |
Operating Profit | 168 | 236 | 351 | 297 | 95.2 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 141 | 200 | 340 | 386 | -3.07 |
Provision for Income Taxes | |||||
Net Income After Taxes | 131 | 173 | 283 | 332 | 22.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 123 | 173 | 282 | 332 | 24.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 123 | 173 | 282 | 332 | 24.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.11 | 6.37 | 7.91 | 8.5 | 0.949 |
Dividends per Share |